Bli medlem
Bli medlem

Du är här

2015-12-18

Biotec Pharmacon ASA: Biotec Pharmacon: Invitation to Capital Markets Day on 11 February 2016

(Tromsø, 18 December 2015) Biotec Pharmacon ASA (OSE:Biotec) will host
a Capital Markets Day (CMD) on Thursday, 11 February 2016 following
the Q4 presentation.

Time: 08.30 - 11.00

Location: Hotel Continental, Stortingsgaten 24/26, Oslo

Speakers will be:
Svein Lien (CEO),
Jethro Holter (MD, ArcticZymes),
Stuart Devine (VP Marketing, Woulgan®) and
Rolf Engstad (CSO)

Breakfast will be served prior to the presentations. For practical
reasons, investors, analysts and journalists coming to the event are
encouraged to register via email to ir@biotec.no by 4 February 2016.

The Q4 and the CMD presentations will be webcasted live and made
available on www.biotec.no and through NewsWeb on 11 February 2016.

For additional information and booking of one-to-one meetings
following the CMD, please contact:

CFO
Børge Sørvoll
+47 95 29 01 87
borge.sorvoll@biotec.no

About Biotec Pharmacon ASA:

Biotec Pharmacon ASA is the parent company of Biotec BetaGlucans AS
and ArcticZymes AS. Biotec BetaGlucans develops, manufactures and
markets novel immunomodulating products, including Woulgan®, a
premium priced product in the advanced wound care market. ArcticZymes
develops, produces and markets enzymes of marine origin used in
molecular DNA technologies and diagnostics, representing growth
markets where rapid technological developments are creating a strong
demand for new and improved enzymes.

-----------------------------------------------------------
http://feed.ne.cision.com/client/waymaker1/WOLReleaseFile.aspx?id=335228...
http://mb.cision.com/Public/1090/9887727/a148f6ad9b08cb12.pdf

Författare WKR

Tala om vad ni tycker

Tala om vad ni tycker

Ni är just nu inne på en betaversion av nya aktiespararna. Lämna gärna feedback på vad ni tycker i formuläret nedan.